MegaPro Biomedical submits FDA application for Phase III MPB-1523 trial
MegaPro Biomedical Co Ltd has submitted an application to the FDA to conduct a Phase III trial on MPB-1523.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.